Composition comprising gv1001 for preventing or treating macular degeneration
AssigneeGemVax & KAEL Co., Ltd.
InventorSANG JAE KIM
Life of this patent
Estimating the term…
Abstract
A method for treating a macular degeneration in a subject who has the macular degeneration or is at risk of developing the macular degeneration includes administering an effective amount of a composition comprising a peptide having the amino acid sequence of SEQ ID NO: 1 as an active ingredient to the subject. The composition exhibits effects of reducing retinal degeneration and is safe to the living body to thus involve less side effects including abnormal response.
Claims7
1-8. (canceled)
A method for treating a macular degeneration in a subject who has the macular degeneration or is at risk of developing the macular degeneration, the method comprising:
- administering an effective amount of a pharmaceutical composition comprising a peptide having the amino acid sequence of SEQ ID NO:
- 1 as an active ingredient, to the subject.
A kit for preventing or treating macular degeneration, comprising
- a pharmaceutical composition, comprising a peptide having the amino acid sequence of SEQ ID NO:
- 1 as an active ingredient;
- and
- instructions describing a method for treating macular degeneration.
A method for delaying a macular degeneration in a subject who has the macular degeneration or is at risk of developing the macular degeneration, the method comprising providing an effective amount of a health functional food comprising a peptide having the amino acid sequence of SEQ ID NO:
- 1 as an active ingredient, for oral intake by the subject.
Dependencies are inferred from the claim text.